Psychological Impact of the Health Measures Generated by the COVID19 in Adolescents (COVADO)

Psychological Impact of the Health Measures Generated by the SarsCov-2 Pandemic in Adolescents (COVADO)

The lockdown of the French population is a health measure put in place in response to the pandemic linked to a new coronavirus, SARS-CoV-2 (Covid-19). After a health campaign to recommend hygienic "barrier gestures" and social distancing, the decision to confine the population at the national level was decided by the executive from Monday 16 March to Monday 11 May 2020. The national confinement implies the restriction of movement to the strict necessary, outings near the home and the closure of schools and communities. These decisions have led to an unprecedented state of stress for the entire French population, the consequences of which are unknown in the short, medium or long term. The objectives of this study are to evaluate the psychological impact of the confinement on adolescents with or without chronic disease and also the difficulties and fears engendered by deconfinement .

Study Overview

• Status: Completed
• Conditions: Psychology, Social; Psychological Adaptation
• Intervention / Treatment: Other: Questionnaire

• Study Type: Observational
• Enrollment (Actual): 50

Contacts and Locations

Study Locations

• France
  • Creteil, France, 94000
    • Camille JUNG

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 11 years to 18 years (Child, Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

The study will be proposed to all the adolescents followed in the Centre hospitalier Intercommunal de Creteil for a chronic disease or not.

Description

Inclusion Criteria:

• Adolescents aged 11 to 18 years old
• Previous consultation in the Centre Hospitalier intercommunal de Creteil
• Agree to participate

Exclusion Criteria:

• Lack of computer equipment or internet connection

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Anxiety score from the Generalized Anxiety Disorder 7 (GAD-7) questionnaire	Scale 0-21	At inclusion

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Depression score from the Adolescent Depression Rating Scale (ADRS) questionnaire	Scale 0-60	At inclusion
Post traumatic score questionnaire: Children's Revised Impact of Events Scales -CRIES13	8 items that are scored on a four-point scale and 3 sub scales: intrusion (4 items); avoidance (4 items) and arousal (5 items)	At inclusion
Presence or absence of difficulty in falling asleep, sleeping	a question on the quality and quantity of sleep will be asked to the teenager on a questionnaire	At inclusion
Presence or absence of feeding difficulty	a question on the presence or absence of feeding difficulty will be asked to the teenager on a questionnaire	At inclusion
Presence or absence of difficulty performing physical activity	a question on the presence or absence of difficulty performing physical activity will be asked to the teenager on a questionnaire	At inclusion
Presence or absence of toxic consomption (drug, acohol) during the lockdown	a question on the presence or absence of toxic consomption will be asked to the teenager on a questionnaire	At inclusion
Mean duration time in front of screen (hours per day)		At inclusion
Presence or absence of difficulties with social interactions	A question on the presence or absence of difficulties with social interactions will be asked to the teenager on a questionnaire	At inclusion
Presence or absence of difficulties with familial interactions	Presence or absence of difficulties with familial interactions	At inclusion

Collaborators and Investigators

• Sponsor: Centre Hospitalier Intercommunal Creteil

Study record dates

Study Major Dates

• Study Start (Actual): January 10, 2019
• Primary Completion (Actual): January 27, 2020
• Study Completion (Actual): February 27, 2020

Study Registration Dates

• First Submitted: May 24, 2020
• First Submitted That Met QC Criteria: May 27, 2020
• First Posted (Actual): May 28, 2020

Study Record Updates

• Last Update Posted (Estimate): January 11, 2023
• Last Update Submitted That Met QC Criteria: January 10, 2023
• Last Verified: January 1, 2023

More Information

Terms related to this study

• Other Study ID Numbers: COVADO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No